The chart shows the distribution of publications by all Research.com ranked scientists in the field of Engineering and Technology in 2026. The highlighted bar marks where James M. Kelly sits on this spectrum.
This scientist: 228 publications — 58th percentile
58% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 804 publications or more.
The chart shows the D-index (discipline H-index) distribution of Engineering and Technology scientists ranked by Research.com in 2026. The highlighted bar marks where James M. Kelly sits on this spectrum.
This scientist: 50 D-Index — 59th percentile
59% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 107 D-Index or more.
James M. Kelly is affiliated with the University of California, Berkeley in the United States. Their research focuses primarily on the intersection of medicine, radiology, nuclear medicine, and imaging, with significant contributions to oncology and cancer research as well. Kelly's work integrates knowledge across several subfields, including pulmonary and respiratory medicine, molecular biology, and the study of biomedical imaging techniques.
Kelly has published extensively in areas related to radiopharmaceutical chemistry and applications, medical imaging techniques and applications, peptidase inhibition and analysis, cardiac structural anomalies and repair, chemotherapy-induced cardiotoxicity and mitigation, radioactive decay and measurement techniques, and cardiac imaging and diagnostics.
The frequent venues for Kelly's publications include Nuclear Medicine and Biology, Molecular Imaging and Biology, Analytical Biochemistry, Circulation, and Translational Oncology. These venues reflect the scientist's focus on both the development and clinical application of imaging agents and therapeutic ligands, often at the intersection of nuclear medicine and oncology.
Kelly has collaborated extensively, with frequent coauthors including John W. Babich, Thomas M. Jeitner, Anja Wacker, Chulhee Lee, and Alejandro Amor-Coarasa. These collaborations likely contribute to multidisciplinary research projects bridging chemistry, imaging, and clinical applications.
Among Kelly's recent publications are:
The described publications exhibit Kelly's emphasis on theranostic ligands, positron emission tomography (PET) tracers, and molecular probes targeting various proteins relevant to cancer and cardiac functions.
Farzad Naeim;James M. Kelly
James M Kelly
James Marshall Kelly
Farzad Naeim;James M. Kelly
R. S. Jangid;J. M. Kelly
James M. Kelly
J. M. Kelly;R. I. Skinner;A. J. Heine
R. I. Skinner;J. M. Kelly;A. J. Heine
Ian D. Aiken;Douglas K. Nims;Andrew S. Whittaker;James M. Kelly
Chan Ghee Koh;James M. Kelly
James M. Kelly;Dimitrios Konstantinidis
James M. Kelly
J. M. Kelly;G. Leitmann;A. G. Soldatos
James M. Kelly;Dimitrios A. Konstantinidis
James M. Kelly
José A. Inaudi;James M. Kelly
Chan Ghee Koh;James M. Kelly
Peter W. Clark;Ian D. Aiken;James M. Kelly;Masahiko Higashino
James M. Kelly
James M. Kelly
If you think any of the details on this page are incorrect, let us know.
University of California, San Francisco
Université Catholique de Louvain
University of Utah
Nihon University
Collège de France
University of Guelph
Oregon State University
Feinstein Institute for Medical Research
Australian National University
University of Bordeaux
Stanford University
Nanjing University
King Saud University
University College London
University of Maine
Technical University of Munich
